Aspen Dental donates $2,300 to Oral Cancer Foundation for cancer detection and treatment

NewsGuard 100/100 Score

Aspen Dental (www.aspendent.com) announced today that the company will donate $2,300 to the Oral Cancer Foundation as part of its commitment to oral cancer detection and treatment. The amount represents a $5 donation for every Vizilite Plus® screening conducted at Aspen Dental offices during Oral, Head, and Neck Cancer Awareness Week (April 12-18, 2010). Vizilite Plus is a blue-light, "glowstick" technology that helps detect oral cancer.

According to the Oral Cancer Foundation, more than 35,000 Americans are diagnosed with oral or pharyngeal cancer each year, and oral cancer is responsible for approximately 8,000 deaths annually. Oral cancer is often discovered late in its development, which means that the death rate is particularly high.

Aspen Dental has a longstanding commitment to oral cancer awareness. Most recently, Aspen Dental sponsored Oral Health America's National Spit Tobacco Education Program (NSTEP, www.nstep.org), at the Little League Baseball World Series in August 2009. The NSTEP program educates youth and their parents about the risks of smokeless tobacco use.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tumor microbiomes offer new insights for enhancing cancer therapies